Home LiteratureArticle Details
PMID: 9557708 Published · ppublish English Journal Article

The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.

Journal of virology ·Vol. 72 ·No. 5 ·1998-05-00 ·Pages 4192-204

Roper RL, Wolffe EJ, Weisberg A, Moss B

Abstract

The vaccinia virus (VV) A33R gene encodes a highly conserved 23- to 28-kDa glycoprotein that is specifically incorporated into the viral outer envelope. The protein is expressed early and late after infection, consistent with putative early and late promoter sequences. To determine the role of the protein, two inducible A33R mutants were constructed, one with the late promoter and one with the early and late A33R promoter elements. Decreased A33R expression was associated with small plaques that formed comets in liquid medium. Using both an antibiotic resistance gene and a color marker, an A33R deletion mutant, vA33delta, was isolated, indicating that the A33R gene is not essential for VV replication. The plaques formed by vA33delta, however, were tiny, indicating that the A33R protein is necessary for efficient cell-to-cell spread. Rescue of the large-plaque phenotype was achieved by inserting a new copy of the A33R gene into the thymidine kinase locus, confirming the specific genetic basis of the phenotype. Although there was a reduction in intracellular virus formed in cells infected with vA33delta, the amount of infectious virus in the medium was increased. The virus particles in the medium had the buoyant density of extracellular enveloped viruses (EEV). Additionally, amounts of vA33delta cell-associated extracellular enveloped viruses (CEV) were found to be normal. Immunogold electron microscopy of cells infected with vA33delta demonstrated the presence of the expected F13L and B5R proteins in wrapping membranes and EEV; however, fully wrapped vA33delta intracellular enveloped viruses (IEV) were rare compared to partially wrapped particles. Specialized actin tails that propel IEV particles to the periphery and virus-tipped microvilli (both common in wild-type-infected cells) were absent in cells infected with vA33delta. This is the first deletion mutant in a VV envelope gene that produces at least normal amounts of fully infectious EEV and CEV and yet has a small-plaque phenotype. These data support a new model for VV spread, emphasizing the importance of virus-tipped actin tails.

MeSH Terms
Actin Cytoskeleton Actins/metabolism Centrifugation, Density Gradient Cloning, Molecular Culture Media Fluorescent Antibody Technique Gene Deletion Gene Expression Genes, Viral Glycoproteins/genetics,physiology HeLa Cells Humans Intracellular Fluid Microvilli Mutagenesis Phenotype Vaccinia virus/physiology Viral Envelope Proteins/genetics,physiology Viral Plaque Assay Virion
Chemicals
Actins Culture Media Glycoproteins Viral Envelope Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Roper R L
Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland 20892-0445, USA.
Wolffe E J
Weisberg A
Moss B
References (52)
52 references, click to expand
  1. An antigenic difference between intracellular and extracellular rabbitpox virus.
    J Gen Virol. 1971 Oct;13(1):9-17 PMID: 4108676
  2. Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus.
    J Gen Virol. 1971 Oct;13(1):19-25 PMID: 5130569
  3. Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis.
    Virology. 1971 Dec;46(3):533-43 PMID: 4109523
  4. Differences between extracellular and intracellular forms of poxvirus and their implications.
    Prog Med Virol. 1973;16:86-108 PMID: 4356899
  5. High-voltage electron microscope study of the release of vaccinia virus from whole cells.
    J Virol. 1976 May;18(2):636-43 PMID: 1271521
  6. Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles.
    J Gen Virol. 1976 Jul;32(1):63-72 PMID: 986420
  7. Vaccinia virus reexamined: development and release.
    Virology. 1976 Aug;73(1):43-58 PMID: 960564
  8. Interaction of assembled progeny pox viruses with the cellular cytoskeleton.
    Virology. 1979 Oct 15;98(1):142-53 PMID: 573519
  9. Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine.
    J Virol. 1979 Nov;32(2):614-22 PMID: 501802
  10. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.
    J Gen Virol. 1980 Sep;50(1):89-100 PMID: 7441216
  11. Fluorescence microscopical analysis of the life cycle of vaccinia virus in chick embryo fibroblasts. Virus-cytoskeleton interactions.
    Exp Cell Res. 1981 Mar;132(1):81-7 PMID: 7193591
  12. Conditions for pox virus-specific microvilli formation studied during synchronized virus assembly.
    Virology. 1981 Sep;113(2):556-64 PMID: 7269254
  13. Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.
    J Virol. 1981 Sep;39(3):903-13 PMID: 7288920
  14. Electron microscopic study on vaccinia virus release.
    Arch Virol. 1983;75(3):213-8 PMID: 6838377
  15. Release of vaccinia virus from FL cells infected with the IHD-W strain.
    J Electron Microsc (Tokyo). 1983;32(2):125-40 PMID: 6644226
  16. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.
    J Virol. 1985 Sep;55(3):651-9 PMID: 4020961
  17. Nucleotide sequence of the vaccinia virus hemagglutinin gene.
    Virology. 1986 Apr 30;150(2):451-62 PMID: 3008418
  18. Localization and fine structure of a vaccinia virus gene encoding an envelope antigen.
    J Virol. 1986 Jun;58(3):757-64 PMID: 3701927
  19. Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.
    Mol Cell Biol. 1985 Aug;5(8):1918-24 PMID: 3018537
  20. Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes.
    Proc Natl Acad Sci U S A. 1987 Sep;84(18):6417-21 PMID: 3476956
  21. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.
    J Virol. 1988 Jun;62(6):1849-54 PMID: 3130492
  22. Transfer of the inducible lac repressor/operator system from Escherichia coli to a vaccinia virus expression vector.
    Proc Natl Acad Sci U S A. 1989 Apr;86(8):2549-53 PMID: 2649884
  23. Structure of vaccinia virus early promoters.
    J Mol Biol. 1989 Dec 20;210(4):749-69 PMID: 2515286
  24. Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants.
    Virology. 1990 Apr;175(2):372-84 PMID: 2183466
  25. Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein.
    Virology. 1990 Sep;178(1):81-91 PMID: 2389560
  26. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.
    J Virol. 1990 Oct;64(10):4884-92 PMID: 2398531
  27. Inducer-dependent conditional-lethal mutant animal viruses.
    Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1511-5 PMID: 1899929
  28. Vaccinia virus: a tool for research and vaccine development.
    Science. 1991 Jun 21;252(5013):1662-7 PMID: 2047875
  29. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
    J Virol. 1991 Nov;65(11):5910-20 PMID: 1920620
  30. Vaccinia virus morphogenesis is interrupted when expression of the gene encoding an 11-kilodalton phosphorylated protein is prevented by the Escherichia coli lac repressor.
    J Virol. 1991 Nov;65(11):6101-10 PMID: 1920628
  31. Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation.
    Virology. 1992 Mar;187(1):251-60 PMID: 1736527
  32. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.
    J Virol. 1992 Mar;66(3):1610-21 PMID: 1738204
  33. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.
    Virology. 1992 Jun;188(2):801-10 PMID: 1585649
  34. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.
    J Virol. 1992 Jul;66(7):4170-9 PMID: 1602540
  35. A PCR-based method for manipulation of the vaccinia virus genome that eliminates the need for cloning.
    Biotechniques. 1992 Nov;13(5):764-71 PMID: 1418979
  36. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.
    J Virol. 1992 Dec;66(12):7217-24 PMID: 1433514
  37. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes.
    Cell. 1992 Dec 11;71(6):963-72 PMID: 1333889
  38. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks.
    J Cell Biol. 1993 May;121(3):521-41 PMID: 8486734
  39. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.
    J Virol. 1993 Jun;67(6):3319-25 PMID: 8497053
  40. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene.
    J Virol. 1996 Jun;70(6):3753-62 PMID: 8648710
  41. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes.
    Science. 1996 Aug 9;273(5276):813-6 PMID: 8670425
  42. The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus.
    J Virol. 1997 May;71(5):3904-15 PMID: 9094667
  43. Re-emergence of human monkeypox in Zaire in 1996. Monkeypox Epidemiologic Working Group.
    Lancet. 1997 May 17;349(9063):1449-50 PMID: 9164323
  44. The development of vaccinia virus in Earle's L strain cells as examined by electron microscopy.
    J Biophys Biochem Cytol. 1961 Aug;10:475-503 PMID: 13719413
  45. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
    Virology. 1993 Jun;194(2):627-37 PMID: 8503178
  46. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
    J Virol. 1993 Aug;67(8):4732-41 PMID: 8331727
  47. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network.
    J Virol. 1994 Jan;68(1):130-47 PMID: 8254722
  48. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Virology. 1994 Oct;204(1):376-90 PMID: 8091668
  49. E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses.
    Biotechniques. 1995 Sep;19(3):352-4, 356 PMID: 7495543
  50. Actin-based motility of vaccinia virus.
    Nature. 1995 Dec 7;378(6557):636-8 PMID: 8524400
  51. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
    J Virol. 1996 Jan;70(1):272-81 PMID: 8523536
  52. Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination.
    Virology. 1971 Dec;46(3):507-32 PMID: 4944855
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1998-05-00
Pages
4192-204
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC109648
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]